Related Experiment Video
Updated: May 3, 2026

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
26.1K
Next generation sequencing and its application in deciphering head and neck cancer
Maryam Jessri1, Camile S Farah1
1The University of Queensland, UQ Centre for Clinical Research, Herston, Qld 4029, Australia; The University of Queensland, School of Dentistry, Brisbane, Qld 4000, Australia.
Oral Oncology
|January 21, 2014
Summary
This review compares next-generation sequencing (NGS) platforms for managing head and neck squamous cell carcinoma (HNSCC). It highlights NGS
Area of Science:
- Oncology and Genomics
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous malignancy often linked to lifestyle factors and viral infections.
- Current HNSCC management relies on cancer stage, utilizing surgery, radiotherapy, chemotherapy, or combinations.
- Early diagnosis is crucial for improving patient prognosis in HNSCC.
Purpose of the Study:
- To review and compare commercially available next-generation sequencing (NGS) platforms.
- To assess the clinical applicability of NGS in managing HNSCC.
- To provide guidance on technical and ethical considerations for NGS in clinical settings.
Main Methods:
- Comparative analysis of various commercial NGS platforms.
- Literature review focusing on NGS applications in HNSCC.
- Examination of technical specifications and clinical utility data.
Main Results:
- NGS platforms offer advancements for basic research and potential clinical applications.
- Careful evaluation of data and guidelines is necessary before widespread clinical adoption of NGS.
- Specific NGS platforms show promise for HNSCC management, requiring further validation.
Conclusions:
- NGS technologies are evolving rapidly, impacting cancer research and diagnostics.
- Clinical implementation of NGS for HNSCC requires rigorous assessment of platforms and protocols.
- Further research is needed to optimize NGS utilization for improved HNSCC patient outcomes.

